Medtech Executive-in-Residence (EIR) – Breakthrough Bio

Medtech Executive in Residence (EIR)MassChallenge — Breakthrough Bio, Medtech TrackLocation: Boston, MA (hybrid) |Reports to: Sr. Director of Programs| Compensation: $1,800/month, part-time (approx. 5 to 8 hrs/week), October 2026 through July 2027 About MassChallenge and Breakthrough BioMassChallenge is the global network for innovators working to solve massive challenges. We connect startups, experts, corporations, and communities to grow and transform businesses and economies. Our mission is to equip bold entrepreneurs to disrupt the status quo and create meaningful change. Our mission is BIG, and thus we are a team that gives 100% every day. Our values ensure we stay true to our mission and our core beliefs.Breakthrough Bio is a MassChallenge global accelerator for the next generation of international healthcare and life sciences startups, anchored in Boston with additional U.S. engagement in San Diego and Philadelphia. The program brings together elite, high-potential biotech and medtech startups from partner countries, including Taiwan (in partnership with the Development Center for Biotechnology) and Israel (in partnership with the National Technological Innovation Authority), and supports them through a milestone-driven acceleration journey toward U.S. market, regulatory, clinical, and investor readiness.Breakthrough Bio is more ambitious and later-stage than most MassChallenge programs. Startups typically join at Seed to Series A, and every cohort company is working toward three core outcomes: new partnerships, new funding, and new regulatory milestones. The Executive in Residence's (EIR's) mentorship and personal network are central to helping startups reach these outcomes.For medtech startups, the program emphasizes U.S. commercialization, hospital and provider engagement, payer and reimbursement strategy, FDA device pathway planning, and medtech corporate partnership formation. MassChallenge is currently seeking a Medtech Executive in Residence (EIR) to join our Boston team and support this cohort. Why You Should Join UsMassChallenge was just named the #2 accelerator in the U.S. and #1 in Massachusetts by TIME and Statista, with 85% of the ranking driven by feedback from the founders we serve. That puts us among the very best in the country. It also gives us a new target. We are building on that recognition, growing what works, and raising our ambitions for what MassChallenge can do next. If you are looking for a place where there is real energy behind the work and plenty left to build, we want to talk to you! Position SummaryMassChallenge is seeking a Medtech Executive in Residence (EIR) to support the Breakthrough Bio medtech track. As the EIR, your mission is fourfold:Support Startup Growth in Medtech: Provide technical and strategic guidance to startups building medical devices, diagnostics, imaging, surgical tools, wearables, implantables, or connected devices.Mentor and Advise Founders: Deliver targeted mentorship on FDA device pathways, reimbursement and payer strategy, hospital procurement, and clinical champion development.Strengthen the Ecosystem: Engage with medtech corporates, providers, payers, and investors across Boston, San Diego, and Philadelphia to expand the program's impact.Mobilize Your Network: Rally your own professional and industry contacts, including medtech corporates, providers, payers, and investors, to attend and engage directly with cohort startups at the program's flagship convenings in Boston, California, and Philadelphia. Overview of Program Timeline and EIR CommitmentThis EIR engagement spans the full Breakthrough Bio medtech cohort cycle, October 2026 through July 2027, at approximately 5 to 8 hours per week.Sourcing and evaluating applicants (October 2026)Curriculum development and network activation (November 2026)The time commitment is not evenly distributed. It scales up around three flagship convenings, where in-person attendance is expected:Boston Kickoff (week of January 11, 2027)California Market Access Sprint / LSI USA (week of March 15, 2027)Philadelphia Finale (week of June 7, 2027)Between convenings, the EIR supports the cohort remotely through mentor sessions, office hours, and curriculum input, concentrated in two phases:Virtual sessions and office hours (February 2027)Virtual sessions and office hours (April to May 2027) LocationThis EIR is a hybrid role based in Boston, MA. In-person engagement is expected for the Boston Kickoff, the California Market Access Sprint / LSI USA, and the Philadelphia Finale; travel costs for these engagements will be covered by MassChallenge using our T&E Policy. The EIR is expected to use these convenings to rally their own network to attend and engage with cohort startups. Additional travel may be required to support program milestones, with associated travel costs covered as well. What You'll DoTechnical Expertise: Share subject matter knowledge across FDA device pathways (510(k), De Novo, PMA, Breakthrough Device), reimbursement, and provider workflow integration.Curriculum Support: Contribute to the Boston Kickoff curriculum, including hospital and health system procurement, value analysis committee navigation, clinical champion and KOL development, and channel/distributor strategy.Mentorship and Coaching: Provide one-on-one and group mentorship on pilot/POC design, regulatory strategy, and payer engagement.Network Building: Connect founders with medtech corporates, providers, payers, and hospital systems in Boston and San Diego.Network Mobilization: Personally invite and rally medtech corporate, provider, payer, and investor contacts from your own network to attend and actively engage with startups at the Boston Kickoff, California Market Access Sprint / LSI USA, and Philadelphia Finale.LSI USA Readiness: Help founders prepare for LSI USA '27 in Dana Point, including meeting strategy and investor/strategic partner targeting.Ecosystem Representation: Represent MassChallenge and Breakthrough Bio at Boston, San Diego, and Philadelphia ecosystem convenings. Key DeliverablesDeliverables are tied directly to the Breakthrough Bio program phasing and reporting cadence:Provide input on medtech curriculum content ahead of the Boston Kickoff (week of January 11, 2027), particularly FDA device pathways, reimbursement/payer strategy, and hospital procurement, and rally your network to attend and engage with startups on-site.Deliver mentor sessions or office hours during the virtual execution period (January to March 2027), including LSI USA 2027 preparation.Support the California Market Access Sprint (week of March 15, 2027), anchored around LSI USA '27 in Dana Point, including meeting strategy and investor/strategic partner targeting, and rallying your own contacts to attend and engage with cohort startups.Support Philadelphia medtech ecosystem preparation (March 22 to June 4, 2027), including payer/provider engagement strategy and clinical champion/KOL planning.Participate in the Finale Showcase, Demo Day, and Philadelphia medtech ecosystem activation (week of June 7, 2027), rallying your network to attend and engage with startups at the Finale.Provide qualitative input on founder milestone progress to support Midpoint and Final Outcomes Reports against program targets (75% average milestone completion; 30%+ of startups advancing financing, clinical/commercial/adoption, or U.S. market entry progress within 12 months of finale; stage-appropriate regulatory milestones). Success MetricsStartup Outcomes: New partnerships formed, funding secured, and regulatory milestones achieved by cohort companies.Technical Readiness: Demonstrated progress of startups toward regulatory, reimbursement, and commercialization milestones.Ecosystem Engagement: Increased visibility of MassChallenge and Breakthrough Bio in the medtech innovation ecosystem, including the volume and quality of external stakeholders you mobilize to attend program convenings.Founder Impact: Positive satisfaction scores and testimonials from participating startups. What You BringMedtech Expertise: Proven track record as a founder, technical leader, or senior executive in medical devices, diagnostics, or related healthcare technology, ideally with experience supporting Seed to Series A companies.Network and Relationships: Strong, mobilization-ready connections with medtech corporates, providers, payers, hospital systems, and investors, and a demonstrated willingness to bring those contacts directly into the program.Mentorship Experience: High emotional intelligence (EQ) and a passion for guiding early-stage entrepreneurs.Commitment to Impact: Dedication to supporting founders building medical device and healthcare technology solutions.Operational Knowledge: Familiarity with FDA device pathways, reimbursement processes, and hospital procurement and value-analysis processes. CompensationThis is a part-time engagement at $1,800 per month (approximately 5 to 8 hours per week), from October 2026 through July 2027. MassChallenge offers competitive nonprofit-scale compensation, commensurate with experience, and reviewed for internal equity. Equal Opportunity EmployerMassChallenge is proud to be an Equal Opportunity Employer. We seek individuals from a broad variety of backgrounds with varying levels of experience who have a desire to do meaningful work. We recruit, employ, train, compensate, and promote regardless of race, color, gender, gender identity, religion, national origin, ancestry, disability, age, veteran status, sexual orientation, or any other characteristic protected by law